LOXO was sold for 8b and it was only phase 1. We are in our second phase 2. The first phase 2 showed fanastic results for TNBC - 89% vs 0% disease free after 55 months. So not just okay results - fantastic results.
So are we worth more than $8b? I would say yes.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links